Proactive Agenda

What’s missing in the current drug pricing plan

Last week, a congressional forum looked at the role pharmacy benefit managers (PBMs) play in determining what patients pay out of pocket for prescription medicines. The forum provided an important reminder of how these middlemen operate in an opaque system that often leaves patients paying far more than they should for medicines. And it’s also …

What’s missing in the current drug pricing plan Read More »

ICYMI: PhRMA CEO speaks at STAT Summit about government price setting

As part of the annual STAT Summit, PhRMA President and CEO Stephen J. Ubl recently spoke with STAT’s Matthew Herper to discuss the many unintended consequences expected from the latest drug pricing plan on Capitol Hill, as well as the biopharmaceutical industry’s plans to help build a better health care system that improves patient access …

ICYMI: PhRMA CEO speaks at STAT Summit about government price setting Read More »

Making medicines more affordable: Sharing savings at the pharmacy counter

Common-sense reforms can help ensure everyone benefits from America’s engine of innovation and receives the care they need and deserve. In this series, we’re taking a closer look at PhRMA’s advocacy efforts to make medicines more affordable, part of our patient-centered agenda which aims to lower barriers between our industry’s medical innovations and patients who need …

Making medicines more affordable: Sharing savings at the pharmacy counter Read More »

Three things to know about so-called Medicare “negotiation” polling

As policymakers continue to push partisan drug pricing proposals, several polls misrepresenting voter opinion have been circulated to try and justify these flawed policies. These polls fail to educate voters on the policy arguments and trade-offs and consistently ignore voters’ true concerns, as well as patient voices speaking out against these types of proposals.

In the current health care debate, Congress has lost sight of what matters to U.S. voters

For months Congress has been debating massive changes to the nation’s social safety net, one of which is the highly popular Medicare prescription drug benefit. Unfortunately, much of what is being debated around that benefit today loses sight of the real barriers to a better health care system. It is a fact that too often, …

In the current health care debate, Congress has lost sight of what matters to U.S. voters Read More »

Making medicines more affordable: Modernizing Medicare

Common-sense reforms can help ensure everyone benefits from America’s engine of innovation and receives the care they need and deserve. In this series, we’re taking a closer look at PhRMA’s advocacy efforts to make medicines more affordable, part of our patient-centered agenda which aims to lower barriers between our industry’s medical innovations and patients who need them. 

Making Medicines More Affordable: Making coupons count

Common-sense reforms can help ensure everyone benefits from America’s engine of innovation and receives the care they need and deserve. In this series, we’re taking a closer look at PhRMA’s efforts to make medicines more affordable, part of our patient-centered agenda which aims to lower barriers between our industry’s medical innovations and patients who need them.

What they are saying: Government price setting for medicines is not the answer

America’s biopharmaceutical companies continue to voice the dangers of current proposals in Washington that would allow the government to set prices for medicines. While it’s being called government “negotiation,” it really is government price setting, and it would have significant ramifications for research and development efforts that fuel innovation, sacrificing by a conservative estimate more …

What they are saying: Government price setting for medicines is not the answer Read More »

The patient experience: Insurance design hurdles lead to access issues for too many Americans, including communities of color and the chronically ill.

3 in 10 insured Americans still face a financial barrier to care and some of the most vulnerable patients are also those more likely to experience barriers in accessing their care, according to our inaugural Patient Experience Survey (PES). This is apparent when we look at the disproportionate application of insurer tools – including prior …

The patient experience: Insurance design hurdles lead to access issues for too many Americans, including communities of color and the chronically ill. Read More »

ICYMI: New study confirms policies like H.R. 3 could significantly reduce drug development

A new study from economists at the University of Chicago examined the impact that government price-setting policies for medicines, like those in H.R. 3, could have if implemented. The economists found that a policy like H.R. 3 could reduce investment in the research and development (R&D) of new medicines by up to 60% between 2021 …

ICYMI: New study confirms policies like H.R. 3 could significantly reduce drug development Read More »

Government “negotiation” could have devastating consequences for Medicare enrollees

Some members of Congress are considering significant changes to Medicare that could have a devastating effect on millions of Americans. Proponents call these changes government “negotiation,” but what they are actually proposing is anything but that. These politicians want to repeal a key provision of the Medicare Part D program that protects robust coverage and …

Government “negotiation” could have devastating consequences for Medicare enrollees Read More »

Protecting Medicare from government interference

For more than a decade, Medicare Part D has provided seniors and people with disabilities with affordable and comprehensive prescription medicine coverage. Several surveys show that more than 9 in 10 Part D enrollees are satisfied with their coverage, helping tens of millions of patients manage a number of chronic and life-threatening conditions, including diabetes, …

Protecting Medicare from government interference Read More »

Ask About Adherence: 3 factors impacting medication adherence for patients with diabetes and how our proactive affordability solutions can help

Earlier this year, PhRMA released a proactive agenda with common-sense, patient-centered reforms to improve access to quality, affordable health care. The urgency of building a stronger, more resilient health care system is apparent in light of new data from the U.S. Centers for Disease Control and Prevention that show an increasing number of deaths from …

Ask About Adherence: 3 factors impacting medication adherence for patients with diabetes and how our proactive affordability solutions can help Read More »

Data shows voters strongly support protecting access to their medicines

In our current health care system, the Medicare Part D program helps ensure seniors and people with disabilities have access to the prescription medicines they need. While more than 90% of seniors are very satisfied with their Part D prescription drug coverage and want to protect it, we also must tackle rising out-of-pocket costs for …

Data shows voters strongly support protecting access to their medicines Read More »

Medicare “negotiation” proposals threaten Americans’ access to medicines

While more than 90% of seniors and people with disabilities report that they are very satisfied with their Medicare Part D prescription drug coverage, they also acknowledge concerns with rising out-of-pocket costs. It is no surprise that this has been a recurring discussion on Capitol Hill with many putting forth proposals aimed at lowering the …

Medicare “negotiation” proposals threaten Americans’ access to medicines Read More »

Building a better health care system: A conversation with Mark Reisenauer, President of Astellas US

Our industry continues to work tirelessly to combat the COVID-19 virus by developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. As we continue our efforts to bring the pandemic to an end, we should not miss the opportunity to learn from it and use those lessons to build a stronger, more …

Building a better health care system: A conversation with Mark Reisenauer, President of Astellas US Read More »

Four solutions Americans support to make health care more affordable

Health care costs and affordability remain a major challenge for most Americans, even among those with insurance. According to a March Gallup poll, nearly one-in-five (18%) U.S. adults report that if they needed access to quality health care today, they would be unable to pay for it. The arrival of the COVID-19 crisis has only …

Four solutions Americans support to make health care more affordable Read More »

H.R. 3 threatens access to medicines, future innovation and American jobs

In the last election, voters made clear that they want quality, affordable health coverage that works when they need it and lower out-of-pocket costs for medicines. And we can achieve those goals, but the drug pricing plan known as H.R. 3 is not the answer. If implemented, it could have devastating consequences for patients’ access …

H.R. 3 threatens access to medicines, future innovation and American jobs Read More »

Our three-part approach to build a better health care system

On April 3, more than four million Americans received a COVID-19 vaccine — the largest single-day vaccination event in human history. For innovators across the pharmaceutical industry, these moments make the years — sometimes decades — of painstaking trial and error worth it.